EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 315 filers reported holding EDITAS MEDICINE INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35 | +75.0% | 4,595 | +81.4% | 0.00% | – |
| Q2 2023 | $20 | +11.1% | 2,533 | -2.1% | 0.00% | – |
| Q1 2023 | $18 | -61.7% | 2,587 | -52.8% | 0.00% | – |
| Q4 2022 | $47 | -100.0% | 5,484 | -42.6% | 0.00% | – |
| Q3 2022 | $116,000 | +13.7% | 9,552 | +10.1% | 0.00% | – |
| Q2 2022 | $102,000 | -95.7% | 8,679 | -93.1% | 0.00% | -100.0% |
| Q1 2022 | $2,375,000 | -1.3% | 124,905 | +37.8% | 0.00% | 0.0% |
| Q4 2021 | $2,406,000 | +32.9% | 90,656 | +105.7% | 0.00% | +50.0% |
| Q3 2021 | $1,810,000 | -23.9% | 44,069 | +4.9% | 0.00% | -33.3% |
| Q2 2021 | $2,378,000 | +8707.4% | 41,995 | +6360.8% | 0.00% | – |
| Q1 2021 | $27,000 | -87.6% | 650 | -79.0% | 0.00% | – |
| Q4 2020 | $217,000 | +10750.0% | 3,101 | +3825.3% | 0.00% | – |
| Q2 2020 | $2,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |